Adjunctive Treatment for Decreasing Symptoms of Schizophrenia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

d-cycloserine

DRUG

glycine

DRUG

placebo

Trial Locations (5)

10982

Nathan S Kline Institute for Psychiatric Research, Orangeburg

11004

Zucker Hillside Hospital, Glen Oaks

21228

Maryland Psychiatric Research Center, Baltimore

90073

UCLA/VA Greater Los Angeles Health Care System, Los Angeles

91531

Ezrath Nashim Association, Sarah Herzog Memorial Hospital, Jerusalem

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

The Zucker Hillside Hospital

OTHER

collaborator

Nathan Kline Institute for Psychiatric Research

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

Sarah Herzog Hospital

UNKNOWN

collaborator

University of Maryland, College Park

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT00222235 - Adjunctive Treatment for Decreasing Symptoms of Schizophrenia | Biotech Hunter | Biotech Hunter